H.B. Fuller rejects $1.2 billion BAS offer
H.B. Fuller (NYSE:FUL) announced that its board rejected Ancora’s unsolicited, non-binding proposal to acquire its Building Adhesives Solutions business, stating that the offer undervalues the segment.
Todas as matérias desta categoria, das mais recentes às mais antigas.
H.B. Fuller (NYSE:FUL) announced that its board rejected Ancora’s unsolicited, non-binding proposal to acquire its Building Adhesives Solutions business, stating that the offer undervalues the segment.
Spruce Biosciences (NASDAQ:SPRB) announced that it completed two pre-BLA meetings with the U.S. Food and Drug Administration supporting its planned submission of a Biologics License Application for tralesinidase alfa enzyme replacement therapy in Sanfilippo Syndrome Type B.
The9 (NASDAQ:NCTY) reported unaudited net income of US$32 million for the quarter ended June 30, 2026, up more than 39% from the previous quarter, driven mainly by fair-value recognition of 9BIT tokens.
Insmed (NASDAQ:INSM) announced that Japan’s Ministry of Health, Labour and Welfare approved BRINSUPRI (brensocatib 25 mg) for adults and pediatric patients aged 12 years and older with non-cystic fibrosis bronchiectasis.
BriaCell (NASDAQ:BCTX) announced that Bria-MEL+ has passed a key genetic engineering milestone, moving the personalized whole-cell melanoma immunotherapy vaccine candidate toward potential clinical development.
Vanda Pharmaceuticals (NASDAQ:VNDA) announced that the European Commission granted orphan designation to imsidolimab for the treatment of generalized pustular psoriasis, following a positive opinion from the EMA Committee for Orphan Medicinal Products.
NAPCO Security Technologies (NASDAQ:NSSC) reported fiscal Q4 2026 revenue of $55.8 million, up 10% year-over-year, driven by growth in recurring service and equipment revenue.
Treasury Secretary Scott Bessent is due to unveil details of the US plan to economically isolate Iran and its trading partners during a press conference Monday. Tyler Kendall reports on Bloomberg Television.
Scinai Immunotherapeutics (NASDAQ:SCNI) reported first-half 2026 revenue of $949 thousand, up from $773 thousand a year earlier, driven mainly by its acquired Yavne contract development and manufacturing organization operations.
Dan Ives, partner and senior managing director at Yorkville Ives & Co., previews quarterly earnings from Nvidia as the company tells customers that the prices of servers containing its artificial intelligence chips are going up more than 15% in many cases.
Martin Marietta (NYSE:MLM) completed its previously announced combination with Lhoist North America, a subsidiary of Lhoist Group, effective August 21, 2026.
Gogoro (NASDAQ:GGR) reported Q2 2026 revenue of $70.6 million, up 7.3% year-over-year, supported by higher hardware and other revenue.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade